Allarity Therapeutics Inc (NASDAQ:ALLR) has a beta value of 0.29 and has seen 0.61 million shares traded in the recent trading session. The company, currently valued at $2.63M, closed the recent trade at $1.86 per share which meant it gained $0.2 on the day or 12.19% during that session. The ALLR stock price is -35706.45% off its 52-week high price of $666.00 and 26.88% above the 52-week low of $1.36. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.17 million shares traded. The 3-month trading volume is 452.86K shares.
The consensus among analysts is that Allarity Therapeutics Inc (ALLR) is Buy stock at the moment, with a recommendation rating of 1.00. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 1 have rated it as a Hold, with 1 advising it as a Buy. 0 have rated the stock as Underweight. The expected earnings per share for the stock is -8.52.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Allarity Therapeutics Inc (NASDAQ:ALLR) trade information
Sporting 12.19% in the green today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the ALLR stock price touched $1.86 or saw a rise of 11.43%. Year-to-date, Allarity Therapeutics Inc shares have moved -99.44%, while the 5-day performance has seen it change 26.69%. Over the past 30 days, the shares of Allarity Therapeutics Inc (NASDAQ:ALLR) have changed -37.71%. Short interest in the company has seen 0.14 million shares shorted with days to cover at 0.15.
Allarity Therapeutics Inc (ALLR) estimates and forecasts
Figures show that Allarity Therapeutics Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -95.86% over the past 6 months, with this year growth rate of 98.73%, compared to 17.40% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was 57.56% over the past 5 years.
ALLR Dividends
Allarity Therapeutics Inc is expected to release its next earnings report on 2024-Aug-05 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
